Published by Iain Gilbert on 22nd April 2025
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it had received "positive high-level results" from a Phase III trial on its Enhertu candidate, developed in conjunction with Daiichi Sankyo.
URL: http://www.digitallook.com/dl/news/story/35025498/...